Loading clinical trials...

Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization | Clinical Trials | Clareo Health

TERMINATEDPHASE1

Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization

Pilot Study of Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization

NCT01744054•Washington University School of Medicine

View on ClinicalTrials.gov

Summary

The successful localization of the y90 microspheres by PET/MR and/or PET/CT scans would be a useful tool in individualizing patient care after the radioembolization procedure. The information from a PET/MR or PET/CT scan would allow for early evaluation of the technical success of the procedure.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Participant must successfully complete the MRI screening form if receiving an MRI
•Participant must be scheduled to undergo radioembolization for any indication
•Participant must be ≥ 18 years of age
•Participant must be able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document

Exclusion Criteria

•Participant must not have any contraindications to MRI scanning
•Patient must not be pregnant or breastfeeding
•If agreeing to MRI contrast, participant must not have renal insufficiency (glomerular filtration rate (GFR \< 30 mL/min/1.73 m2) measured within the past 60 days
•If agreeing to MRI contrast, participant must not be on dialysis
•If agreeing to MRI contrast, participant must not have had a prior allergic reaction to gadolinium-based contrast agents
•PET/MRI or PET/CT is not able to be scheduled within 72 hours of radioembolization

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States

Key Dates

Start Date

October 25, 2012

Primary Completion Date

April 3, 2017

Completion Date

April 3, 2017

Last Updated

March 5, 2018

Enrollment

ACTUAL participants

Conditions

Liver Neoplasms

Interventions

PET/MR

DEVICE

PET/CT

DEVICE

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

NCT07225114

Breast CancerKidney Neoplasms+1 more

View study

COMPLETEDNA

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

NCT04618692

Liver FailureLiver Diseases+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization

Inclusion Criteria

Exclusion Criteria

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Short Term Surgical Outcomes of Anatomical Versus Non Anatomical Laparoscopic Liver Resection for Liver Tumors

NAC to Prevent Cisplatin-induced Hearing Loss